Study Information
Status: Active, Not Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Greater Sacramento Valley, East Bay, Palo Alto/Santa Cruz, San Francisco, Santa Rosa, Modesto, Solano/Vallejo, San Mateo
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Recruitment for this Trial is Temporarily on Hold